Autolus Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell AUTL and other ETFs, options, and stocks.About AUTL
Autolus Therapeutics Plc is a biopharmaceutical company, which engages in the development and commercialization of gene therapies. It uses proprietary and modular T cell programming technologies that are designed to recognize cancer cells, break down their defense mechanisms, and attack and kill these cells.
CEOChristian Martin Itin
CEOChristian Martin Itin
Employees647
Employees647
HeadquartersLondon, Greater London
HeadquartersLondon, Greater London
Founded2018
Founded2018
Employees647
Employees647
AUTL Key Statistics
Market cap400.52M
Market cap400.52M
Price-Earnings ratio-1.74
Price-Earnings ratio-1.74
Dividend yield—
Dividend yield—
Average volume2.38M
Average volume2.38M
High today$1.72
High today$1.72
Low today$1.42
Low today$1.42
Open price$1.65
Open price$1.65
Volume2.58M
Volume2.58M
52 Week high$5.00
52 Week high$5.00
52 Week low$1.11
52 Week low$1.11
AUTL News
TipRanks 17h
Autolus Therapeutics to Present R&D Update April 23Autolus Therapeutics ( (AUTL) ) has shared an announcement. On April 23, 2025, Autolus Therapeutics will present a corporate update at an R&D investor event, w...
Analyst ratings
100%
of 11 ratingsBuy
100%
Hold
0%
Sell
0%